Insider Transactions Reported by 20 Insiders of ImmunoGen, Inc.

Location
Waltham, MA

There are no Buy or Sell transactions made by insiders since 26 Dec 2024

ImmunoGen, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Anna Berkenblit Svp & Chief Medical Officer $3.38M 30 Jun 2023
Thomas Ryll SVP, Technical Operations $2.51M 30 Jun 2021
Kristen Harrington-Smith Svp & Chief Commercial Officer $2.21M 15 Nov 2022
Stacy Ann Coen Svp & Chief Business Officer $1.38M 12 Feb 2024
Mark Enyedy CHIEF EXECUTIVE OFFICER, Director $898K 12 Feb 2024
Susan ALTSCHULLER Svp And Cfo $564K 20 May 2022
Renee Lentini Vp & Prin Acctg Officer $245K 12 Feb 2024
Daniel Char Svp & Chief Legal Officer $0 12 Feb 2024
STEPHEN MCCLUSKI Director $0 12 Feb 2024
Richard John Wallace Director $0 12 Feb 2024
Isabel Kalofonos Svp & Chief Commercial Officer $0 12 Feb 2024
Theresa Wingrove Svp Of Regulatory Affairs $0 12 Feb 2024
Kristine Peterson Director $0 12 Feb 2024
DEAN J. MITCHELL Director $0 12 Feb 2024
Mark Alan Goldberg Director $0 12 Feb 2024
Stuart A. Arbuckle Director $0 12 Feb 2024
Helen M. Thackray Director $0 12 Feb 2024
Tracey L. McCain Director $0 12 Feb 2024
Lauren White Svp, Cfo And Pfo $0 12 Feb 2024
MICHAEL VASCONCELLES Evp R&D & Medical Affairs $0 12 Feb 2024

Recent Insider Transactions by Companies or Individuals for ImmunoGen, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.